Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Sub. : Intimation of Investor Meetings (Non-Deal Roadshow) during November 28 and 29, 2018 Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the management of the Company shall be meeting investors/ analysts in Mumbai, India on November 28 and 29, 2018 as part of a Non-Deal Roadshow. We enclose details...
27-11-2018
Bigul

Announcement under Regulation 30 (LODR)-Credit Rating

 Sub: Credit Rating Dear Sirs, We enclose a communication pertaining to upgrade in outlook of Credit Rating of Jubilant Pharma Limited. This is for your kind information and records.
02-11-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Dear Sirs, Sub.: Submission of copies of published Unaudited Consolidated Financial Results In continuation of our letter dated October 22, 2018, we enclose copies of the Unaudited Consolidated Financial Results for the quarter ended September 30, 2018 published on October 23, 2018 in MINT (English) and HINDUSTAN (Hindi). This is for information and records.
23-10-2018
Bigul

Sub: Compliance With Regulation 52(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 We enclose a certificate dated October 22, 2018 received from Vistra ITCL (India) Limited, Debenture Trustee, pursuant to Regulation 52 (5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the Non-Convertible Debentures of the Company listed on National Stock Exchange of India Limited.
22-10-2018

Jubilant Life Q2 profit rises 67% to 210 crore

 Jubilant Life today reported 67.18% rise in consolidated net profit to 209.77 crore for second quarter ended 30 September, as against 125.47 crore in the year-ago period
22-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Change in Directorate

 Dear Sirs, Re.: Appointment of Directors Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board has, at its meeting held on October 22, 2018, appointed the following Directors with immediate effect:...
22-10-2018
Bigul

Results For The Quarter Ended September 30, 2018

 Dear Sirs, In terms of Regulation 33 read with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'Listing Regulations'), we wish to inform you that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended September 30, 2018 were approved by the Board of Directors of the Company at its meeting held today at 1.30 p.m. and concluded at 2.30 p.m....
22-10-2018
Bigul

Shareholding for the Period Ended September 30, 2018

 Jubilant Life Sciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here
19-10-2018
Bigul

Regulation 40(10) Compliance

 As per Regulation 40(9) and Regulation 40(10) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a Certificate obtained from a Practising Company Secretary for the period ended September 30, 2018. We request you to take the same on record.
18-10-2018
Bigul

Announcement under Regulation 30 (LODR)-Newspaper Publication

 Sub.: Submission of copies of newspaper advertisements In continuation of our letter dated October 15, 2018, we enclose copies of the advertisements published on October 16, 2018, in MINT (English) and HINDUSTAN (Hindi) with respect to notice of the Board Meeting scheduled to be held on October 22, 2018.
16-10-2018
Next Page
Close

Let's Open Free Demat Account